{
    "identifier" : "d",
    "label" : "l",
    "items": [
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item4AE",
        "l": "4Ae) Acute and chronic graft versus host disease"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item2AK",
        "l": "2Ak) Other Myeloproliferative and Myelodysplastic disorders including pediatric disorders (e.g. JMML)"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#SectionClinicalHematologyBenign",
        "l": "1) Clinical Hematology: Benign",
        "children": [
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#RedCellDisorders"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#NonMalignantWhiteBloodCellDisorders"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#ConsultativeHematology"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#PlateletDisordersAndAngiopathies"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#BoneMarrowFailure"}
        ],
        "selectable": true
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#SectionClinicalHematologyMyeloidMalignancies",
        "l": "2) Clinical Hematology: Myeloid Malignancies",
        "children": [
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#MyeloproliferativeAndMyelodysplasticNeoplasms"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#AcuteMyeloidLeukemiaAndLeukemiasOfAmbiguousLineage"}
        ],
        "selectable": true
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#SectionClinicalHematologyLymphoidMalignanciesAndPlasmaCellDisorders",
        "l": "3) Clinical Hematology: Lymphoid Malignancies and Plasma Cell Disorders",
        "children": [
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#T-CellLymphomasAndNK-CellNeoplasms"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#HodgkinLymphoma"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#OtherSpecialEntities"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#B-CellNeoplasms"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#PlasmaCellNeoplasms"}
        ],
        "selectable": true
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#SectionClinicalHematologyStemCellTransplantationAndSpecialTherapy",
        "l": "4) Clinical Hematology: Stem Cell Transplantation and Special Therapy",
        "children": [
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#TreatmentOfHematologicalDisorders"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#StemCellTransplantation"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#CellAndGeneTherapy"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#SupportiveAndEmergencyCare"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#InfectiousComplications"}
        ],
        "selectable": true
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#SectionLaboratoryDiagnosis",
        "l": "5) Laboratory Diagnosis",
        "children": [
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#GoodLaboratoryPractice"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#ImmunophenotypingByFlowCytometry"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#BasicConcepts"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#BloodCountAndMorphology"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#OtherLaboratoryTechniques"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#GeneticsAndMolecularBiology"}
        ],
        "selectable": true
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#SectionThrombosisAndHemostasis",
        "l": "6) Thrombosis and Hemostasis",
        "children": [
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#LaboratoryManagement"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#AcquiredBleedingDisorders"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#CongenitalBleedingDisorders"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#ThromboticDisorders"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#PlateletDisorders"}
        ],
        "selectable": true
      },
	        {
        "d": "http://www.ehaweb.org/rdf/2011-passport#SectionTransfusionMedicine",
        "l": "7) Transfusion Medicine",
        "children": [
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#GuidelinesAndRegulationsForUseOfBloodAndBloodComponents"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#AdministrationOfTransfusionAndManagementOfComplications"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Immunohematology"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#ManagementOfSpecialConditions"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#BloodDonation"}
        ],
        "selectable": true
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#SectionGeneralSkills",
        "l": "8) General Skills",
        "children": [
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#CommunicationSkills"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#HematologicalCareInTheElderlyPatient"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Pharmacovigilance"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#EndOfLife"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#EthicsAndLaw"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#GoodClinicalPracticeClinicalTrials"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#EvidenceBasedMedicineCriticalAppraisal"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#PsychosocialIssues"}
        ],
        "selectable": true
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item1EA",
        "l": "1Ea) Genetic counseling"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item7DG",
        "l": "7Dg) Hemovigilance program"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item3AC",
        "l": "3Ac) BurkittÂ´s lymphoma"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#AcuteMyeloidLeukemiaAndLeukemiasOfAmbiguousLineage",
        "l": "2B) Acute Myeloid Leukemia and Leukemias of Ambiguous Lineage",
        "children": [
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item2BF"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item2BA"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item2BC"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item2BE"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item2BD"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item2BB"}
        ],
        "selectable": true
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item4AC",
        "l": "4Ac) Administration of high-dose therapy"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#EndOfLife",
        "l": "8H) End Of Life",
        "children": [
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item8HE"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item8HC"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item8HB"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item8HD"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item8HG"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item8HF"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item8HA"}
        ],
        "selectable": true
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item4BB",
        "l": "4Bb) Clinical potential and limits of gene therapy"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item8HC",
        "l": "8Hc) Recognizing physical, psychological, social or spiritual distress and identifying the need for specialist palliative care"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item7DD",
        "l": "7Dd) Rate and conditions of administration and monitoring"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item8AG",
        "l": "8Ag) Strategic and economic implications of combining drugs and clinical biomarkers (personalized medicine)"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item6ED",
        "l": "6Ed) Post-thrombotic complications"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item1AD",
        "l": "1Ad) Pure red cell aplasia"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item2BB",
        "l": "2Bb) AML with MDS related changes"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#PsychosocialIssues",
        "l": "8F) Psychosocial Issues",
        "children": [
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item8FB"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item8FC"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item8FA"}
        ],
        "selectable": true
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#BloodDonation",
        "l": "7A) Blood Donation",
        "children": [
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item7AB"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item7AA"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item7AD"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item7AC"}
        ],
        "selectable": true
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item1AL",
        "l": "1Al) Erythrocytosis (other than PV)"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item1EC",
        "l": "1Ec) Hematological manifestations of non hematological disorders"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#EthicsAndLaw",
        "l": "8D) Ethics and Law",
        "children": [
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item8DD"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item8DA"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item8DH"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item8DE"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item8DF"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item8DB"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item8DG"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item8DC"}
        ],
        "selectable": true
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item8EA",
        "l": "8Ea) Communication with patients with hematological disorders (including communicating sad, bad and difficult information and managing patients with different cultural backgrounds)"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item7EA",
        "l": "7Ea) Hemolytic disease of the newborn"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item7CC",
        "l": "7Cc) Blood derivatives (incl. immunoglobulins)"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item8HD",
        "l": "8Hd) Potential indicators of the quality of end-of-life care "
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item6CE",
        "l": "6Ce) Other bleeding disorders (e.g. deficiency of factor XIII,  XI, X, VII, V and II, and hypofibrinogenaemia)"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item6DC",
        "l": "6Dc) Heparin-induced thrombocytopenia "
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item3AD",
        "l": "3Ad) Other aggressive B-cell lymphomas (e.g. unclassifiable, primary mediastinal large B-cell lymphoma, intravascular, plasmablastic, ALK+ large B-cell lymphoma)"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#GoodLaboratoryPractice",
        "l": "5B) Good Laboratory Practice",
        "children": [
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item5BA"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item5BC"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item5BD"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item5BB"}
        ],
        "selectable": true
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item3BB",
        "l": "3Bb) Peripheral T-cell lymphoma, NOS"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item7AD",
        "l": "7Ad) Preparation and preservation of standard and special blood components (Whole Blood; Red cells; Plasma; Platelets. Cryoprecipitate; irradiated; leukocyte depleted; washed; pathogen reduced; Pediatric Units)"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item3BA",
        "l": "3Ba) Acute lymphoblastic leukemia/lymphoblastic lymphoma of T-cell origin"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item8HG",
        "l": "8Hg) The national legal requirements regarding euthanasia "
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item5AA",
        "l": "5Aa) Hematopoiesis"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item3AB",
        "l": "3Ab) Diffuse large B-cell lymphoma"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#GeneticsAndMolecularBiology",
        "l": "5F) Genetics and Molecular Biology",
        "children": [
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item5FA"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item5FC"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item5FB"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item5FD"}
        ],
        "selectable": true
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item7BC",
        "l": "7Bc) Minor red cell antigens and antibodies "
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item8GB",
        "l": "8Gb) The impact of age on the pharmacodynamics, pharmacokinetics and risks of drugs used to treat hematologic disorders "
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item8FC",
        "l": "8Fc) Patientsâ rights according  to national legislation"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item3ED",
        "l": "3Ed) Monoclonal immunoglobulin deposition diseases (amyloidosis)"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item3BD",
        "l": "3Bd) Other T- and NK-cell lymphomas (incl. AILT, T-PLL, T-LGL, NK-cell lymphoma/leukemia)"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item5AE",
        "l": "5Ae) Basic concepts of transcription and translation, epigenetic regulation, signal transduction, cell cycle regulation and apoptosis"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item4CE",
        "l": "4Ce) Hematological malignancies in pregnancy"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item6AC",
        "l": "6Ac) Establishing ranges, including relevance to gender and age"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item1AN",
        "l": "1An) Secondary hemochromatosis"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item6EF",
        "l": "6Ef) Acquired thrombotic tendency, (e.g. APS, HIT, PNH and MPN) "
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item8HA",
        "l": "8Ha) Communication with patients and family about death and dying"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item2BD",
        "l": "2Bd) Other AML"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item6DA",
        "l": "6Da) Platelet structure, function and vessel wall interactions"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#BloodCountAndMorphology",
        "l": "5C) Blood Count and Morphology",
        "children": [
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item5CB"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item5CF"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item5CD"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item5CG"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item5CC"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item5CA"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item5CE"}
        ],
        "selectable": true
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item1AJ",
        "l": "1Aj) Acquired non-immune hemolytic anemias"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item6AA",
        "l": "6Aa) Techniques for assessing coagulation and platelets"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item7EI",
        "l": "7Ei) Multi-component collection "
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item3EB",
        "l": "3Eb) Solitary plasmacytoma "
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item8CD",
        "l": "8Cd) Procedures and systematic post-marketing surveillance studies aimed at assessing the full safety profile of drugs (e.g., risk management plan, risk evaluation mitigation strategy, post-authorization safety studies)"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item1DA",
        "l": "1Da) Acquired platelet function disorders"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item5CC",
        "l": "5Cc) Preparation, fixation, staining, reading and reporting of peripheral blood smears and bone marrow aspirates"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item8HE",
        "l": "8He) Collaboration of the multi-professional team with patients and family"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item1AG",
        "l": "1Ag) Red blood cell membrane disorders (e.g.Spherocytosis)"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item4DD",
        "l": "4Dd) Cytomegalovirus (CMV) infection"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item5EB",
        "l": "5Eb) Essential cellular markers applied in the diagnosis of hematological conditions (e.g. lineage, progenitor and differentiation markers)"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#AdministrationOfTransfusionAndManagementOfComplications",
        "l": "7D) Administration of Transfusion and Management of Complications",
        "children": [
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item7DA"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item7DB"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item7DD"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item7DF"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item7DE"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item7DC"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item7DG"}
        ],
        "selectable": true
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#MyeloproliferativeAndMyelodysplasticNeoplasms",
        "l": "2A) Myeloproliferative and Myelodysplastic Neoplasms",
        "children": [
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item2AI"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item2AG"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item2AA"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item2AC"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item2AE"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item2AK"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item2AJ"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item2AH"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item2AF"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item2AB"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item2AD"}
        ],
        "selectable": true
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item5FC",
        "l": "5Fc) Other techniques for detection of genetic and epigenetic aberrations (e.g. Western blot, CGH, SNP, gene expression profiling, high-throughput sequencing, microRNA assays, methylation studies, proteomics)"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item2AH",
        "l": "2Ah) CMML"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item7CE",
        "l": "7Ce) Massive transfusion (in surgery, trauma, pregnancy, etc)"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item6CC",
        "l": "6Cc) Hemophilia A and B"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#AcquiredBleedingDisorders",
        "l": "6B) Acquired Bleeding Disorders",
        "children": [
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item6BF"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item6BA"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item6BG"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item6BC"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item6BB"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item6BE"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item6BD"}
        ],
        "selectable": true
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item5AB",
        "l": "5Ab) Stem cell biology"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#TreatmentOfHematologicalDisorders",
        "l": "4C) Treatment of Hematological Disorders",
        "children": [
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item4CB"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item4CD"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item4CA"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item4CC"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item4CE"}
        ],
        "selectable": true
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item8DA",
        "l": "8Da) Principles of medical ethics central to the physician-patient relationship (e.g., principle of primacy of patientsâ welfare, patientsâ autonomy, social justice) "
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item8AA",
        "l": "8Aa) Fundamental principles of evidence based medicine"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item4EC",
        "l": "4Ec) Superior vena cava syndrome "
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item2AJ",
        "l": "2Aj) MDS intermediate and high risk disease"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item3DA",
        "l": "3Da) Lymphomas in immunodeficient patients (incl. PTLD, HIV-associated lymphomas)"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#BoneMarrowFailure",
        "l": "1B) Bone Marrow Failure",
        "children": [
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item1BD"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item1BB"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item1BC"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item1BA"}
        ],
        "selectable": true
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item3AI",
        "l": "3Ai) Chronic lymphocytic leukemia/small lymphocytic lymphoma/monoclonal B cell lymphocytosis"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item7BA",
        "l": "7Ba) Cross matching, direct and indirect antiglobulin (Coombs) tests, ABO and Rh typing of red blood cells"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item3CA",
        "l": "3Ca) Nodular lymphocyte predominant HL "
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item8HB",
        "l": "8Hb) Decision making related to end-of-life situations"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item1BC",
        "l": "1Bc) Fanconiâs anemia"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item2BC",
        "l": "2Bc) Therapy related AML and MDS"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item5CF",
        "l": "5Cf) Histopathology in regard to hematological conditions. Review of trephine biopsy, pathological lymph node and other tissue biopsies for diagnosis with a pathologist"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item6EB",
        "l": "6Eb) Venous thromboembolism"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item6EJ",
        "l": "6Ej) Adverse drug reactions to anticoagulant, antiplatelet and thrombolytic therapy "
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#CellAndGeneTherapy",
        "l": "4B) Cell and Gene Therapy",
        "children": [
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item4BD"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item4BB"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item4BC"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item4BA"}
        ],
        "selectable": true
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#ConsultativeHematology",
        "l": "1E) Consultative Hematology",
        "children": [
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item1EC"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item1EE"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item1EB"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item1ED"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item1EA"}
        ],
        "selectable": true
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item3AF",
        "l": "3Af) Follicular lymphoma"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item3AA",
        "l": "3Aa) Acute lymphoblastic leukemia/lymphoblastic lymphoma of B-cell origin"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#BasicConcepts",
        "l": "5A) Basic Concepts",
        "children": [
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item5AE"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item5AC"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item5AB"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item5AA"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item5AD"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item5AF"}
        ],
        "selectable": true
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Immunohematology",
        "l": "7B) Immunohematology",
        "children": [
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item7BC"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item7BA"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item7BB"}
        ],
        "selectable": true
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item4BD",
        "l": "4Bd) Tumor vaccines"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item3CB",
        "l": "3Cb) Classical HL"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#LaboratoryManagement",
        "l": "6A) Laboratory Management",
        "children": [
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item6AB"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item6AA"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item6AC"}
        ],
        "selectable": true
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item2BA",
        "l": "2Ba) AML with recurrent genetic abnormalities"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item6CD",
        "l": "6Cd) Von Willebrandâs disease"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item1AK",
        "l": "1Ak) Other congenital anemias (CDA, sideroblastic anemia)"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item5FB",
        "l": "5Fb) Polymerase chain reaction for the detection of gene mutations, fusion genes, clonality assessment, and gene expression (e.g. reverse transcription-polymerase chain reaction, qualitative and quantitative, sequencing)"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item8BC",
        "l": "8Bc) Applying the Appendix 2 to the Guideline on the evaluation of Anticancer Medicinal Products in Man on confirmatory studies in hematological malignancies (European Medicines Agency)"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item2BE",
        "l": "2Be) Myeloid proliferations related to Down syndrome"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item1CE",
        "l": "1Ce) Hemophagocytic lymphohistiocytosis"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item8BE",
        "l": "8Be) Obtaining the informed consent according to current regulations"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#PlateletDisordersAndAngiopathies",
        "l": "1D) Platelet Disorders and Angiopathies",
        "children": [
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item1DB"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item1DD"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item1DC"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item1DA"},
		  {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item1DE"}
        ],
        "selectable": true
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item4AA",
        "l": "4Aa) Indications, risks and benefits of autologous and allogeneic transplants"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item3EC",
        "l": "3Ec) Plasma cell myeloma (Multiple myeloma)"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item4CC",
        "l": "4Cc) Short and long term complications of chemotherapy and radiotherapy (including infertility and secondary neoplasias)"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item7EC",
        "l": "7Ec) Laboratory work-up of immune hemolytic anemias"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item7EB",
        "l": "7Eb) Neonatal thrombocytopenia and neutropenia"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#B-CellNeoplasms",
        "l": "3A) B-Cell Neoplasms",
        "children": [
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item3AA"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item3AF"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item3AH"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item3AC"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item3AE"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item3AG"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item3AB"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item3AI"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item3AD"}
        ],
        "selectable": true
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item6BD",
        "l": "6Bd) Bleeding related to anticoagulants and antithrombotic therapy"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item7DA",
        "l": "7Da) Information to the patient "
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item4DE",
        "l": "4De) Other viral infections in immunocompromised hosts"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#HematologicalCareInTheElderlyPatient",
        "l": "8G) Hematological Care in the Elderly Patient",
        "children": [
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item8GB"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item8GA"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item8GC"}
        ],
        "selectable": true
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item7AC",
        "l": "7Ac) Donor preparation; venesection, donation screening, donation associated adverse events "
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item1DC",
        "l": "1Dc) Thrombotic thrombocytopenic purpura"
      },
	  {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item1DE",
        "l": "1De) Disorders with teleangiectasias(e.g. Rendu-Osler-Weber disease) {"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item5AC",
        "l": "5Ac) Chromosome and gene structure"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item7EJ",
        "l": "7Ej) Performing therapeutic phlebotomy"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item5BB",
        "l": "5Bb) Laboratory quality management (incl. internal and external quality control)"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item7DC",
        "l": "7Dc) Proper identification of the unit and recipient"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item2AA",
        "l": "2Aa) Chronic myeloid leukemia"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item8BA",
        "l": "8Ba) Identifying the different phases, types and purposes of clinical trials (e.g., phase 1-4, observational studies) as well as understanding the differences between industry-driven and investigator-driven clinical trials "
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item4EB",
        "l": "4Eb) Spinal cord compression"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item8CA",
        "l": "8Ca) Using terms relevant to drug-related harms (e.g., serious adverse event, adverse drug reaction, risk-benefit ratio, toxicity, medication error)"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item6BG",
        "l": "6Bg) Adverse effects of treatment used in acute bleeding (blood products, pro-haemostatic drugs  )"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item3DB",
        "l": "3Db) Cutaneous lymphomas"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item5CE",
        "l": "5Ce) Cytochemical and special stains of blood and bone marrow smears"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#StemCellTransplantation",
        "l": "4A) Stem Cell Transplantation",
        "children": [
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item4AF"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item4AG"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item4AA"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item4AC"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item4AE"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item4AB"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item4AD"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item4AH"}
        ],
        "selectable": true
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item6CG",
        "l": "6Cg) Safety of treatment with blood products and factor concentrates"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item1DD",
        "l": "1Dd) Pseudothrombocytopenia"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Pharmacovigilance",
        "l": "8C) Pharmacovigilance",
        "children": [
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item8CB"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item8CA"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item8CC"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item8CD"}
        ],
        "selectable": true
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item7CB",
        "l": "7Cb) Granulocytes "
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item8EC",
        "l": "8Ec) Communication within a multi-disciplinary team"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item8CC",
        "l": "8Cc) National and EU legislation regarding pharmacovigilance systems"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item8AE",
        "l": "8Ae) Promotion by the industry and its effect on the rational use of diagnostic and therapeutic strategies."
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item1BA",
        "l": "1Ba) Acquired aplastic anemia"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item5ED",
        "l": "5Ed) Post-analytical phase (data analysis and determination of the lineage of cells of interest, clonality and specific subtype of hematological condition)"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item5EE",
        "l": "5Ee) Applications, limitations and prognostic impact for diagnosis and classification, evaluation of minimal residual disease, stem cell quantification"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item4AF",
        "l": "4Af) Pulmonary complications, veno-occlusive disease of the liver, and hemorrhagic cystitis"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item2AE",
        "l": "2Ae) Chronic eosinophilic leukemia"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item1AI",
        "l": "1Ai) Acquired immune hemolytic anemias"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item1EE",
        "l": "1Ee) Hematological manifestations in HIV and other infectious diseases"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#InfectiousComplications",
        "l": "4D) Infectious Complications",
        "children": [
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item4DE"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item4DA"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item4DB"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item4DD"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item4DC"}
        ],
        "selectable": true
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item8FA",
        "l": "8Fa) Responding to normal psychological reactions to hematological diseases "
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item6AB",
        "l": "6Ab) Assays for inhibitors (incl. anti-phospholipid antibodies) "
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item7EE",
        "l": "7Ee) Red cell exchange"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item4AB",
        "l": "4Ab) Criteria for selection of myeloablative or reduced dose preparative regimens"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#ManagementOfSpecialConditions",
        "l": "7E) Management of Special Conditions",
        "children": [
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item7EE"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item7EG"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item7EK"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item7EF"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item7EI"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item7EA"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item7EC"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item7EJ"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item7EB"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item7ED"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item7EH"}
        ],
        "selectable": true
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item8DB",
        "l": "8Db) The purpose and function of the Research Ethics Committee (ERC) and other regulatory bodies that oversee the conduct of clinical investigations"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item3BC",
        "l": "3Bc) Anaplastic large cell lymphoma"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item8DG",
        "l": "8Dg) Assessing quality of life measures"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item5CA",
        "l": "5Ca) Automated complete blood count with white blood cell differential; âflaggingâ; causes of erroneous blood counts"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item4BA",
        "l": "4Ba) Clinical potential and limits of embryonic and adult stem cell therapy. Ethical considerations"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item1AE",
        "l": "1Ae) Thalassemia"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item7EK",
        "l": "7Ek) Special components (Leukoreduced, CMV safe, washed, gamma irradiated, pathogen reduced, cryopreserved)"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item1CB",
        "l": "1Cb) Granulocytopenia/agranulocytosis"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item6CF",
        "l": "6Cf) Considerations in carriers of hemophilia in relation to pregnancy and management of neonates with hemophilia"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item7EG",
        "l": "7Eg) Leukapheresis (therapeutic)"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#ThromboticDisorders",
        "l": "6E) Thrombotic Disorders",
        "children": [
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item6EJ"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item6EB"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item6EE"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item6EI"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item6EA"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item6EG"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item6ED"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item6EF"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item6EH"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item6EC"}
        ],
        "selectable": true
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item7EH",
        "l": "7Eh) Donation by apheresis"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#PlateletDisorders",
        "l": "6D) Platelet Disorders",
        "children": [
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item6DA"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item6DD"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item6DB"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item6DC"}
        ],
        "selectable": true
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item4BC",
        "l": "4Bc) Mesenchymal cells and NK cell therapy"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#CommunicationSkills",
        "l": "8E) Communication Skills",
        "children": [
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item8EC"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item8EA"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item8ED"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item8EB"}
        ],
        "selectable": true
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#T-CellLymphomasAndNK-CellNeoplasms",
        "l": "3B) T-Cell Lymphomas And NK-Cell Neoplasms",
        "children": [
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item3BD"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item3BB"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item3BA"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item3BC"}
        ],
        "selectable": true
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item6EE",
        "l": "6Ee) Thrombophilia (e.g. F V Leiden, II G20210A)"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item4CA",
        "l": "4Ca) Drug therapy including targeted drugs: mechanisms of action, pharmacology and drug resistance "
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#SupportiveAndEmergencyCare",
        "l": "4E) Supportive and Emergency Care",
        "children": [
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item4EA"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item4EB"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item4EC"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item4EF"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item4EE"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item4EG"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item4ED"}
        ],
        "selectable": true
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item3AG",
        "l": "3Ag) Other indolent B-cell lymphomas (e.g. lymphoplasmacytic lymphoma/WaldenstrÃ¶mÂ´s macroglobulinemia, hairy cell leukemia)"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item8AD",
        "l": "8Ad) Definition and disclosure of conflict of interest as well as current conflict-of-interest policies, (e.g., standards of conduct in collaboration between physicians and industry)"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item1BD",
        "l": "1Bd) Other inherited bone marrow failure syndromes (e.g. Blackfan-Diamond, Schwachman)"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item4CD",
        "l": "4Cd) Administration of immunosuppressive agents and growth factors"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item1AM",
        "l": "1Am) Primary hemochromatosis"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item7DE",
        "l": "7De) Fetal, neonatal and pediatric transfusion"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#GoodClinicalPracticeClinicalTrials",
        "l": "8B) Good Clinical Practice / Clinical Trials",
        "children": [
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item8BA"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item8BD"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item8BB"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item8BF"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item8BC"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item8BE"}
        ],
        "selectable": true
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item6CB",
        "l": "6Cb) Taking a relevant bleeding history (previous challenges and family history) with a focused clinical examination"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item4AD",
        "l": "4Ad) Identification and selection of HPC source"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item1AH",
        "l": "1Ah) Red blood cell enzymopathy (e.g. G6PD)"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item1AO",
        "l": "1Ao) Porphyria"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#NonMalignantWhiteBloodCellDisorders",
        "l": "1C) Non Malignant White Blood Cell Disorders",
        "children": [
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item1CF"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item1CB"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item1CD"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item1CA"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item1CC"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item1CE"}
        ],
        "selectable": true
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item5DC",
        "l": "5Dc) Laboratory work-up on iron metabolism and vitamin deficiencies"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#HodgkinLymphoma",
        "l": "3C) Hodgkin Lymphoma",
        "children": [
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item3CA"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item3CB"}
        ],
        "selectable": true
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item8DE",
        "l": "8De) The relationship between healthcare providers and national and European authorities, tissue banks, insurance companies, including legislation"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item6CA",
        "l": "6Ca)  Mechanisms in hemostasis"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item1AB",
        "l": "1Ab) Anemia of chronic disease"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#ImmunophenotypingByFlowCytometry",
        "l": "5E) Immunophenotyping by Flow Cytometry",
        "children": [
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item5ED"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item5EB"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item5EA"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item5EE"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item5EC"}
        ],
        "selectable": true
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item5CB",
        "l": "5Cb) Performing aspiration and biopsy of bone marrow, lumbar puncture and lymph node fine needle aspiration and preparation of slides, touch preparations and trephine rolls"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item5FA",
        "l": "5Fa) Karyotyping (e.g. conventional cytogenetics and fluorescence in situ hybridization)"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item7AB",
        "l": "7Ab) Epidemiology of infectious diseases in the area "
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item4EF",
        "l": "4Ef) Venous access management"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item3DC",
        "l": "3Dc) Primary CNS lymphoma"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item4EE",
        "l": "4Ee) Neurological and psychiatric disturbances"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item5DA",
        "l": "5Da) Hemoglobin analyses (e.g. hemoglobin electrophoresis)"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item8GC",
        "l": "8Gc) Patientsâ care based on a geriatric assessment "
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item7CA",
        "l": "7Ca) Red Cells, Platelets, Plasma"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item2AD",
        "l": "2Ad) Essential thrombocythemia"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item5EA",
        "l": "5Ea) Pre-analytical and analytical phase of flow cytometry of blood, bone marrow, and body fluids (e.g. specimen processing, surface vs. intracytoplasmic staining, acquiring data, gating strategies) "
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item4DC",
        "l": "4Dc) Fungal disease"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item8EB",
        "l": "8Eb) Communication with patientsâ relatives"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item5CD",
        "l": "5Cd) Examination of blood and bone marrow smears for RBC parasites"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item1CD",
        "l": "1Cd) Inherited immune deficiency syndromes"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item6DB",
        "l": "6Db) Congenital platelet disorders, (e.g. Bernard-Soulier syndrome) "
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item1CA",
        "l": "1Ca) Granulocyte dysfunction disorders"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item6BB",
        "l": "6Bb) Disseminated intravascular coagulation (DIC)"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item6BE",
        "l": "6Be) Acquired bleeding disorders in adults (inhibitors to F VIII and vWF) "
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item1EB",
        "l": "1Eb) Hematological manifestations of congenital metabolism disorders"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item7CD",
        "l": "7Cd) Alternatives to allogeneic blood transfusion (autologous blood; use of r-huEPO, iron etc)"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item4EA",
        "l": "4Ea) Hyperleukocytosis, hyperviscosity, and tumor lysis syndrome"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item5BD",
        "l": "5Bd) Normal ranges of laboratory values, with relevance to gender, age and ethnicity"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item7BB",
        "l": "7Bb) HLA typing and anti-HLA antibody detection"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item8HF",
        "l": "8Hf) Best practice in the last hours and days of life, including use of effective symptomatic treatment for patients approaching death"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item8AB",
        "l": "8Ab) Using scientific literature and critically evaluating information"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item6EC",
        "l": "6Ec) Laboratory monitoring and dosing of anticoagulants"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item8DC",
        "l": "8Dc) Professional responsibilities (e.g., respect for patientâs autonomy, non-maleficence, beneficence, justice)"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item5FD",
        "l": "5Fd) Applications, limitations and prognostic impact of genetic and molecular aberrations for diagnosis and classification of hematological disorders, and for evaluating minimal residual disease"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item8CB",
        "l": "8Cb) Recognizing, documenting and treating adverse drug events"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item4DA",
        "l": "4Da) Neutropenic fever"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item6EA",
        "l": "6Ea) Mechanisms and risk-factors in arterial and venous thromboembolism "
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item6EG",
        "l": "6Eg) Treatment and prophylaxis  of venous thromboembolism in pregnancy"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item8ED",
        "l": "8Ed) Presentation of clinical cases"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item7DF",
        "l": "7Df) Transfusion reactions and complications (non-hemolytic, hemolytic, allergic, transfusion-related acute lung injury TRALI, transfusion associated GvHD)"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item8DF",
        "l": "8Df) Cost-effectiveness reasoning and just allocation of scarce resources (e.g. rationalization, rationing, prioritization)"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#RedCellDisorders",
        "l": "1A) Red Cell Disorders",
        "children": [
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item1AO"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item1AL"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item1AC"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item1AG"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item1AK"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item1AN"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item1AB"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item1AE"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item1AF"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item1AJ"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item1AI"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item1AA"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item1AD"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item1AM"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item1AH"}
        ],
        "selectable": true
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item1AF",
        "l": "1Af) Sickle cell disease and other hemoglobinopathies"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item4AG",
        "l": "4Ag) Evaluation of chimerism"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item5BC",
        "l": "5Bc) Hazards and safety"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item7EF",
        "l": "7Ef) Plateletpheresis"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item6BC",
        "l": "6Bc) Bleeding associated with renal and liver disease"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item3DD",
        "l": "3Dd) Histiocytic and dendritic cell neoplasms"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item4CB",
        "l": "4Cb) Administration of standard chemotherapy "
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item2AC",
        "l": "2Ac) Primary Myelofibrosis"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#HematologyPassport",
        "top": true,
        "l": "EHA Hematology Curriculum (version 2)",
        "children": [
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#SectionGeneralSkills"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#SectionClinicalHematologyBenign"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#SectionClinicalHematologyLymphoidMalignanciesAndPlasmaCellDisorders"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#SectionThrombosisAndHemostasis"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#SectionLaboratoryDiagnosis"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#SectionClinicalHematologyMyeloidMalignancies"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#SectionTransfusionMedicine"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#SectionClinicalHematologyStemCellTransplantationAndSpecialTherapy"}
        ],
        "selectable": false
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item5CG",
        "l": "5Cg) Immunostaining in hematological malignancies (lymphoid-lineage, myeloid-lineage and differentiation markers)"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#OtherLaboratoryTechniques",
        "l": "5D) Other Laboratory Techniques",
        "children": [
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item5DB"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item5DC"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item5DA"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item5DD"}
        ],
        "selectable": true
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item4ED",
        "l": "4Ed) Mucositis, vomiting, and pain"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item6EH",
        "l": "6Eh) Specific therapy in thrombotic disorders (e.g. caval filters)"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item1DB",
        "l": "1Db) Immune thrombocytopenia"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item6DD",
        "l": "6Dd) Thrombocytopenia in pregnancy"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item4DB",
        "l": "4Db) Bacterial disease"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item1AA",
        "l": "1Aa) Anemias due to deficiency (iron, B12, folate)"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item5DD",
        "l": "5Dd) Detection of immunoglobulin abnormalities (e.g. protein electrophoresis, immunoelectrophoresis/ immunofixation, cryoglobulin detection, light chain assays) "
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item4AH",
        "l": "4Ah) Mobilization, collection and manipulation of hemopoeitic stem cells"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#PlasmaCellNeoplasms",
        "l": "3E) Plasma Cell Neoplasms",
        "children": [
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item3ED"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item3EA"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item3EC"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item3EB"}
        ],
        "selectable": true
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item1ED",
        "l": "1Ed)  Hematological manifestations related to pregnancy"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item5AF",
        "l": "5Af) Integrating data from various laboratory investigations, relate them to the clinical picture and formulate a diagnosis "
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item2AG",
        "l": "2Ag) Neoplasms with eosinophilia and abnormalities of PDGFR and/or FGFR1"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item8DD",
        "l": "8Dd) Multidisciplinary discussion about ethical dilemmas in clinical practice (e.g., managing patients with reduced autonomy)"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item6BA",
        "l": "6Ba) Massive bleeding in obstetrics, trauma and surgery"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item7AA",
        "l": "7Aa) Council of Europe and other relevant regulations for donor eligibility"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item3EA",
        "l": "3Ea) Monoclonal gammopathy of undetermined significance (MGUS)"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item3AE",
        "l": "3Ae) Mantle cell lymphoma"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item8BD",
        "l": "8Bd) Informing patients with various social, cultural, religious etc. backgrounds of all aspects related to clinical trials"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item6EI",
        "l": "6Ei) Purpura fulminans"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item5AD",
        "l": "5Ad) The role of deoxyribonucleic acid (DNA), ribonucleic acid (RNA) and proteins in normal cellular processes"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item8FB",
        "l": "8Fb) Recognizing psychological distress, socio-economic problems, and identifying the need for specialist resources "
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item2AI",
        "l": "2Ai) MDS low risk disease"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item6BF",
        "l": "6Bf) Acquired bleeding disorders in children"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item8BF",
        "l": "8Bf) Treating and managing patients according to protocol requirements and knowing when to diverge from the protocol"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item8BB",
        "l": "8Bb) Applying the current versions of clinical trial related guidelines and legislation (Directive 2001/20/EC on the implementation of Good Clinical Practice in Clinical Trials, World Medical Association Declaration of Helsinki (2008) on Ethical Principles for Medical Research Involving Human Subjects) "
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#OtherSpecialEntities",
        "l": "3D) Other Special Entities",
        "children": [
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item3DC"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item3DA"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item3DB"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item3DD"}
        ],
        "selectable": true
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#EvidenceBasedMedicineCriticalAppraisal",
        "l": "8A) Evidence Based Medicine / Critical Appraisal",
        "children": [
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item8AD"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item8AA"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item8AF"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item8AE"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item8AG"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item8AH"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item8AB"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item8AC"}
        ],
        "selectable": true
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item8AH",
        "l": "8Ah) Problem based learning techniques"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#GuidelinesAndRegulationsForUseOfBloodAndBloodComponents",
        "l": "7C) Guidelines and Regulations for Use of Blood and Blood Components",
        "children": [
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item7CB"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item7CE"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item7CC"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item7CA"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item7CD"}
        ],
        "selectable": true
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item5BA",
        "l": "5Ba) Principles of laboratory management and organization"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item2BF",
        "l": "2Bf) Acute leukemia of ambiguous lineage"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item1BB",
        "l": "1Bb) Paroxysmal Nocturnal Hemoglobinuria"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item7DB",
        "l": "7Db) Routine vs. emergency transfusions "
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item1AC",
        "l": "1Ac) Anemia due to toxic exposure"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item8AF",
        "l": "8Af) Applying evidence based practice to the management of the individual patient"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item2AF",
        "l": "2Af) Mastocytosis"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item4EG",
        "l": "4Eg) Nutrition"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item8GA",
        "l": "8Ga) The effects of specific changes associated with aging and their impact on normal hematologic processes"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item2AB",
        "l": "2Ab) Polycythemia Vera"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item1CC",
        "l": "1Cc) Lymphopenia and lymphocyte dysfunction syndromes"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item8AC",
        "l": "8Ac) Biostatistics that will allow the trainee to interpret published literature"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item5EC",
        "l": "5Ec) General principles of disease-oriented antibody panels "
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item3AH",
        "l": "3Ah) Marginal Zone lymphomas (e.g. MALT, SMZL)"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item5DB",
        "l": "5Db) Other red blood cell laboratory techniques (e.g. sickling process,  oxygen affinity, red blood cell enzyme assays â pyruvate kinase, glucose-6-phosphate dehydrogenase)"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item1CF",
        "l": "1Cf) Secondary Leukocytosis"
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item8DH",
        "l": "8Dh) Current moral understanding of non-discrimination principles and human rights "
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#CongenitalBleedingDisorders",
        "l": "6C) Congenital Bleeding Disorders",
        "children": [
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item6CG"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item6CF"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item6CD"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item6CC"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item6CA"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item6CB"},
          {"_reference": "http://www.ehaweb.org/rdf/2011-passport#Item6CE"}
        ],
        "selectable": true
      },
      {
        "d": "http://www.ehaweb.org/rdf/2011-passport#Item7ED",
        "l": "7Ed) Plasmapheresis "
      }
    ]
}